Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLUANASDAQ:CLPTNASDAQ:NPCENASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUABlueRiver Acquisition$11.09$10.26▼$11.45$96.90MN/A26,528 shs16,400 shsCLPTClearPoint Neuro$14.70+2.9%$13.27$5.11▼$19.22$411.31M0.97224,474 shs326,337 shsNPCENeuroPace$11.15-0.9%$11.81$5.45▼$15.11$363.04M2.03130,602 shs97,294 shsTCMDTactile Systems Technology$14.58+1.6%$13.83$11.12▼$21.10$345.05M1.21249,581 shs119,579 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUABlueRiver Acquisition0.00%0.00%0.00%0.00%+1.00%CLPTClearPoint Neuro+7.40%+16.75%+8.50%-19.94%+168.61%NPCENeuroPace+2.63%+4.26%-7.25%-23.42%-17.04%TCMDTactile Systems Technology+2.28%+7.65%+7.17%-17.48%-4.59%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUABlueRiver AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACLPTClearPoint Neuro2.2153 of 5 stars3.53.00.00.03.20.00.6NPCENeuroPace3.188 of 5 stars3.43.00.00.03.04.20.6TCMDTactile Systems Technology2.3842 of 5 stars2.01.00.00.02.82.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUABlueRiver Acquisition 0.00N/AN/AN/ACLPTClearPoint Neuro 3.00Buy$25.0070.07% UpsideNPCENeuroPace 2.80Moderate Buy$15.2036.32% UpsideTCMDTactile Systems Technology 2.00Hold$18.0023.46% UpsideCurrent Analyst Ratings BreakdownLatest BLUA, CLPT, NPCE, and TCMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/1/2025CLPTClearPoint NeuroStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $25.003/5/2025NPCENeuroPaceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$19.00 ➝ $20.002/19/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$23.00 ➝ $18.001/30/2025NPCENeuroPaceWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$13.00 ➝ $17.001/28/2025CLPTClearPoint NeuroB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$15.00 ➝ $20.00(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUABlueRiver AcquisitionN/AN/AN/AN/A($0.72) per shareN/ACLPTClearPoint Neuro$31.39M13.10N/AN/A$0.86 per share17.09NPCENeuroPace$79.91M4.54N/AN/A$0.79 per share14.11TCMDTactile Systems Technology$292.98M1.18$1.03 per share14.21$9.18 per share1.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUABlueRiver Acquisition-$5.28MN/A0.00N/AN/AN/AN/A-34.53%N/ACLPTClearPoint Neuro-$22.09M-$0.70N/AN/AN/A-59.64%-62.10%-38.39%5/6/2025 (Estimated)NPCENeuroPace-$32.96M-$0.95N/AN/AN/A-36.74%-205.41%-28.29%5/6/2025 (Estimated)TCMDTactile Systems Technology$28.51M$0.7020.8317.36N/A5.79%9.37%6.75%5/5/2025 (Estimated)Latest BLUA, CLPT, NPCE, and TCMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025NPCENeuroPace-$0.26N/AN/AN/A$21.85 millionN/A5/6/2025Q1 2025CLPTClearPoint Neuro-$0.15N/AN/AN/A$8.21 millionN/A5/5/2025Q1 2025TCMDTactile Systems Technology-$0.07N/AN/AN/A$63.48 millionN/A3/4/2025Q4 2024NPCENeuroPace-$0.25-$0.18+$0.07-$0.18$21.14 million$21.47 million2/26/2025Q4 2024CLPTClearPoint Neuro-$0.15-$0.20-$0.05-$0.20$8.23 million$7.77 million2/18/2025Q4 2024TCMDTactile Systems Technology$0.31$0.40+$0.09$0.40$85.39 million$85.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUABlueRiver AcquisitionN/AN/AN/AN/AN/ACLPTClearPoint NeuroN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUABlueRiver AcquisitionN/A0.010.01CLPTClearPoint NeuroN/A4.543.61NPCENeuroPace6.035.594.77TCMDTactile Systems Technology0.114.363.80Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUABlueRiver Acquisition22.34%CLPTClearPoint Neuro30.08%NPCENeuroPace78.83%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipBLUABlueRiver Acquisition78.98%CLPTClearPoint Neuro6.11%NPCENeuroPace22.20%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLUABlueRiver Acquisition38.73 million1.84 millionNot OptionableCLPTClearPoint Neuro11027.98 million25.90 millionOptionableNPCENeuroPace17032.56 million23.22 millionOptionableTCMDTactile Systems Technology98023.67 million23.36 millionOptionableBLUA, CLPT, NPCE, and TCMD HeadlinesRecent News About These CompaniesTactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025April 21, 2025 | globenewswire.comRenaissance Technologies LLC Has $7.73 Million Stake in Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 21, 2025 | marketbeat.comWasatch Advisors LP Cuts Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 19, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Shares Sold by Kennedy Capital Management LLCApril 15, 2025 | marketbeat.com147,900 Shares in Tactile Systems Technology, Inc. (NASDAQ:TCMD) Purchased by Norges BankApril 14, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Shares Purchased by Arrowstreet Capital Limited PartnershipApril 14, 2025 | marketbeat.comResona Asset Management Co. Ltd. Invests $476,000 in Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 13, 2025 | marketbeat.comPrudential Financial Inc. Sells 66,300 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 12, 2025 | marketbeat.comRaymond James Financial Inc. Invests $330,000 in Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 12, 2025 | marketbeat.comTactile Systems Technology: Interesting Devices Company, Need More ClarityApril 7, 2025 | seekingalpha.comIntegrated Quantitative Investments LLC Purchases Shares of 64,125 Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 6, 2025 | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) Downgraded by StockNews.com to "Buy"March 30, 2025 | marketbeat.comEntryPoint Capital LLC Buys Shares of 19,485 Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 28, 2025 | marketbeat.comThe Returns At Tactile Systems Technology (NASDAQ:TCMD) Aren't GrowingMarch 18, 2025 | finance.yahoo.comTactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 5, 2025 | globenewswire.comA Closer Look At Tactile Systems Technology's EarningsFebruary 26, 2025 | finance.yahoo.comElaine M. Birkemeyer Sells 3,778 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) StockFebruary 25, 2025 | insidertrades.comAnalysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Cross Country Healthcare (CCRN)February 24, 2025 | markets.businessinsider.comRSI Alert: Tactile Systems Technology (TCMD) Now OversoldFebruary 24, 2025 | nasdaq.comB. Riley Securities Downgrades Tactile Systems Technology (TCMD)February 19, 2025 | msn.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2024 Earnings Call TranscriptFebruary 19, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBLUA, CLPT, NPCE, and TCMD Company DescriptionsBlueRiver Acquisition NYSE:BLUABlueRiver Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of technology, media, telecom, and entertainment industries. The company was incorporated in 2020 and is based in San Antonio, Texas.ClearPoint Neuro NASDAQ:CLPT$14.70 +0.41 (+2.87%) Closing price 04:00 PM EasternExtended Trading$14.78 +0.08 (+0.57%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.NeuroPace NASDAQ:NPCE$11.15 -0.10 (-0.89%) Closing price 04:00 PM EasternExtended Trading$11.13 -0.02 (-0.18%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Tactile Systems Technology NASDAQ:TCMD$14.58 +0.23 (+1.60%) Closing price 04:00 PM EasternExtended Trading$14.58 -0.01 (-0.03%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
